ClickCease Compounding Pharmacies Distributing Potentially Contaminated Drugs Across the Country

Compounding Pharmacies Distributing Potentially Contaminated Drugs Across the Country

Many of us have become familiar with the dangers that can be associated with drug compounding facilities. When mixing, sterilization, or other manufacturing or shipping procedures are not followed, drugs manufactured at a compounding pharmacy can be infused with adulterants and then distributed far beyond their place of origin.

On July 23, the Food and Drug Administration issued a warning concerning compounded drugs produced at a Texas specialty pharmacy. After a recent FDA inspection, it became clear that there were unsanitary conditions at the pharmaceutical plant. FDA inspectors found several supposedly sterile drug lots had in fact potentially been exposed to foreign substances in production.

One of the most widely used sterile drugs to come out of this facility is a fluid administered to clear mucus for patients who are suffering from respiratory conditions. The company has now halted production of all sterile drugs (generally those that are injected or administered via intravenous infusion). All non-expired, sterile products produced at the facility have also been recalled.

“Using these products puts patients at an unacceptable risk for series infection,” said FDA spokeswoman Carol Bennett, according to ABC News. The dangerous drugs were distributed across the U.S.

If you were harmed by a dangerous drug, you may be entitled to compensation from the pharmaceutical company that produced it. A personal injury lawyer can tell you more about your rights, can explain your legal options and will be able to strategically guide you through the process of filing a lawsuit.

San Francisco’s Walkup Law firm has been representing patients in compounding pharmacy cases for more than 25 years. If you or a loved one has been injured due to an adulterated drug call us.

SOURCE: ABC News, “FDA Warns of Compounded Drug Recall by Texas Firm,” Associated Press, July 23, 2014